Photodynamic Therapy in Mycosis Fungoides;Terapia fotodinámica en micosis fungoides

Actas Dermo-Sifiliograficas

Volumn 104, Issue 5, 2013, Pages 393-399

  Fernandez Guarino M ^a   Jaen Olasolo P ^b  

^a HOSPITAL CENTRAL DE LA CRUZ ROJA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Mycosis fungoides; Photodynamic therapy; Treatment

Indexed keywords

COSMETIC;

ARTICLE; HUMAN; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY;

EID: 84878358627     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2012.11.017     Document Type: Short Survey

References (30)

1. R. Willemze, E.S. Jaffe, G. Buró, L. Cerroni, E. Berti, and S.H. Swerdlow WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
2. R. Van Doorn, C.W. Van Haselen, P.C. Van Vorst Vader, M.L. Geerts, F. Heule, and M. De Rie Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients Arch Dermatol 136 2000 504 510
3. E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, and R. Knobler Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous task force of the European Organization for Research and Treatment of Cancer (EORTC) Blood 110 2007 1713 1722
4. G. Burg, R. Dummer, A. Haeffner, W. Kempt, and M. Kadin From inflammation to neoplasia: mycosis fungoides evolved from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumours Arch Dermatol 137 2001 949 952
5. R. Dummer, S.A. Michie, D. Kell, J.W. Gould, A.C. Haeffner, and B.R. Smoller Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates J Cutan Pathol 22 1995 11 17
6. E. Olsen, S. Whittaker, Y. Kim, M. Duvic, H.M. Prince, and S.R. Lessin Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphoma, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer J Clin Oncol 29 2011 2598 2607
7. R. Dummer, and M. Dreyling Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 19 2008 72 76
8. S.M. Hortwitz, E.A. Olsen, M. Duvic, P. Porcu, and Y.H. Kim Review of the treatment of mycosis fungoides and Sézary syndrome: a stage-based approach J Natl Compr Canc Netw 6 2008 436 442
9. E.A. Sausville, J.L. Eddy, and R.W. Makuch Histopathologic diagnosis of mycosis fungoides and Sézary syndrome: definition of three distinctive prognostic groups Ann Intern Med 109 1998 372 382
10. K. Svanberg, T. Andersson, D. Killander, I. Wang, U. Stenram, and S. Aderson- Engels Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolaevulinic acid sensitization and laser irradiation Br J Dermatol 130 1994 743 751
11. W.H. Boehncke, K. Koeing, A. Ruck, R. Kauffman, and W. Sterry In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma Acta Derm Venereol 74 1994 201 205
12. K. Rittenhouse-Diakun, H. Van Leengoed, J. Morgan, E. Hryhorenko, G. Paszkiewicz, and J.E. Whitaker The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA) Photochem Photobiol 61 1995 523 528
13. D.W. Edstrom, A. Portwit, and A.M. Ros Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response Acta Derm Venereol 81 2001 184 188
14. D.W. Edstrom, A.W. Ros, and A. Parvit Topical 5-aminolevulinic acid based photodynamic therapy for mycosis fungoides, a study of cell proliferation an apoptosis before and after therapy J Dermatol Sci 16 1998 229
15. L. Leibovici, N. Shoenfeld, H.A. Yehoshua, R. Mamet, E. Rakowsky, and A. Shindel Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer Cancer 62 1988 2297 2300
16. R.V. Lopez, N. Lange, R. Guy, and M.V. Bentley Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters Adv Drug Del Rev 56 2004 77 94
17. D.M. Pariser, N.J. Lowe, D.M. Stewart, M.T. Jarrat, A.W. Lucky, and R.J. Pariser Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial J Am Acad Dermatol 17 2003 45 56
18. R. Ammann, and T.H. Hunziker Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid J Am Acad Dermatol 33 1995 541
19. E. Díez-Recio, B. Zambrano, M.L. Alonso, E. de Eusebio, M. Martín, and J. Cuevas Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature Int J Dermatol 47 2008 410 413
20. D. Eich, H.T. Eich, T.H. Otte, H.G. Ghilescu, and R. Stadler Photodynamishce terapie kuntaker T-zell-lymphome in besonderer lokalisation Hautarzt 50 1999 109 114
21. P. Wolf, R. Fink-Puches, L. Cerroni, and H. Kerl Photodynamic therapy for mycosis fungoides after photosensitization with 5-aminolevulinic acid J Am Acad Dermatol 31 1994 678 680
22. I. Wang, B. Bauer, and S. Anderson-Engels Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin Acta Oftalm Scan 77 1999 182 188
23. A. Orestein, J. Haik, and J. Tamir Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application Dermatol Surg 26 2000 765 769
24. T. Markham, K. Sheehan, and P. Collins Topical 5-aminolevulinic acid photodynamic therapy for tumor-stage mycosis fungoides Br J Dermatol 144 2001 1262
25. J.A. Leman, D.C. Dick, and C.A. Morton Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma Clin Exp Dermatol 27 2002 516 518
26. E.A. Coors, and P. von den Driesch Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma J Am Acad Dermatol 50 2004 363 367
27. C. Zane, M. Venturini, R. Sala, and P. Calzavara-Pinton Photodynamic therapy with mehtylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma Photodermatol Photoinmunol Photomed 22 2006 254 258
28. M. Fernández-Guarino, A. Harto, B. Pérez-García, C. Montull, and P. Jaén Plaque-phase mycosis fungoides treated with photodynamic therapy: results in 12 patients Actas Dermosifiliogr 9 2010 785 791
29. S.J. Whittaker, and F.M. Foss Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sézary syndrome variants of cutaneous T-cell lymphoma Cancer Treat Rev 33 2007 146 160
30. C. Martínez-González, M. Verea-Hernando, and M. Yebra-Pimentel Imiquimod in mycosis fungoides Eur J Dermatol 18 2008 148 152